QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,147 signal articles · 105 in last 24h · 178,672 total before filter · latest 1h ago

105last 24h

3125last 7d

510● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1820 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: NVOSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

InvestorsHub47d agoneutral

Novo Nordisk Considers Acquisitions to Expand Weight-Loss Drug Pipeline as Competition Intensifies

MT Newswires48d agoneutral

Top Midday Stories: Paramount Skydance Settles With US States to Pave Way for Warner Bros. Deal; Anthropic Now Eyeing November IPO

AMZN GS HAL JPM LLY NVO PSKY WBD

24/7 Wall St.82d agoneutral

Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore

ABBV AMGN LLY MRK NVDA NVO PFE

The Wall Street Journal95d agoneutral

Novo Nordisk CEO Remains Open to Bolt-On Acquisitions, But Rules out Transformative Deals

Investor's Business Daily124d agoneutral

Eli Lilly's Market Cap Balloons Again On This IPO's Setback

Zacks156d agoneutral

Can Eli Lilly's 2026 Acquisition Spree Diversify Growth Beyond GLP-1s?

Motley Fool176d agobullish

Is Kailera Therapeutics a Buy After Its Sizzling IPO?

Investor's Business Daily180d agoneutral

Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In Obesity